Royalty Pharma plc

Aardvark Therapeutics’ drug candidates are designed to reduce hunger, but the company worked up enough of an appetite among investors to support the company’s initial public offering – the fifth bioph

Who: Novo Nordisk/Ascendis Pharma What: Novo entered into an agreement to work with Ascendis on the development of longer-acting treatments for metabolic diseases using the latter company’s TransCo

Summer may be over, but the heat is rising in the world of biopharmaceutical financings with some big private and public company financings announced just after the 2 September Labor Day holiday, the

New PureTech Health plc CEO Bharatt Chowrira has been reflecting on a successful first six months of the year, with both the firm's wholly owned pipeline and those of its subsidiaries progressing we